Cancer and the microbiome: Potential applications as new tumor biomarker

Marta Castiglia, Antonio Russo, Giuseppe Bronte, Francesco Passiglia, Ignacio Gil-Bazo, Marc Peeters, Marta Castiglia, Francesco Passiglia, Khan Shahanavaj, Anna P Carreca, Christian Rolfo, José Luis Del Pozo, Christian Diego Rolfo

Risultato della ricerca: Article

20 Citazioni (Scopus)

Abstract

Microbial communities that colonize in humans are collectively described as microbiome. According to conservative estimates, about 15% of all types of neoplasms are related to different infective agents. However, current knowledge is not sufficient to explain how the microbiome contributes to the growth and development of cancers. Large and thorough studies involving colonized, diverse and complex microbiome entities are required to identify microbiome as a potential cancer marker and to understand how the immune system is involved in response to pathogens. This article reviews the existing evidence supporting the enigmatic association of transformed microbiome with the development of cancer through the immunological modification. Ascertaining the connection between microbiome and immunological responses with risk of cancer may direct to explaining significant advances in the etiology of cancer, potentially disclosing a novel paradigm of research for the management and prevention of cancer.
Lingua originaleEnglish
pagine (da-a)317-330
Numero di pagine14
RivistaExpert Review of Anticancer Therapy
Volume15
Stato di pubblicazionePublished - 2015

Fingerprint

Microbiota
Tumor Biomarkers
Neoplasms
Growth and Development
Immune System
Research

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pharmacology (medical)

Cita questo

Cancer and the microbiome: Potential applications as new tumor biomarker. / Castiglia, Marta; Russo, Antonio; Bronte, Giuseppe; Passiglia, Francesco; Gil-Bazo, Ignacio; Peeters, Marc; Castiglia, Marta; Passiglia, Francesco; Shahanavaj, Khan; Carreca, Anna P; Rolfo, Christian; Del Pozo, José Luis; Rolfo, Christian Diego.

In: Expert Review of Anticancer Therapy, Vol. 15, 2015, pag. 317-330.

Risultato della ricerca: Article

Castiglia, M, Russo, A, Bronte, G, Passiglia, F, Gil-Bazo, I, Peeters, M, Castiglia, M, Passiglia, F, Shahanavaj, K, Carreca, AP, Rolfo, C, Del Pozo, JL & Rolfo, CD 2015, 'Cancer and the microbiome: Potential applications as new tumor biomarker', Expert Review of Anticancer Therapy, vol. 15, pagg. 317-330.
Castiglia, Marta ; Russo, Antonio ; Bronte, Giuseppe ; Passiglia, Francesco ; Gil-Bazo, Ignacio ; Peeters, Marc ; Castiglia, Marta ; Passiglia, Francesco ; Shahanavaj, Khan ; Carreca, Anna P ; Rolfo, Christian ; Del Pozo, José Luis ; Rolfo, Christian Diego. / Cancer and the microbiome: Potential applications as new tumor biomarker. In: Expert Review of Anticancer Therapy. 2015 ; Vol. 15. pagg. 317-330.
@article{cf51de60a7ed43b09b9f27eaee2e4603,
title = "Cancer and the microbiome: Potential applications as new tumor biomarker",
abstract = "Microbial communities that colonize in humans are collectively described as microbiome. According to conservative estimates, about 15{\%} of all types of neoplasms are related to different infective agents. However, current knowledge is not sufficient to explain how the microbiome contributes to the growth and development of cancers. Large and thorough studies involving colonized, diverse and complex microbiome entities are required to identify microbiome as a potential cancer marker and to understand how the immune system is involved in response to pathogens. This article reviews the existing evidence supporting the enigmatic association of transformed microbiome with the development of cancer through the immunological modification. Ascertaining the connection between microbiome and immunological responses with risk of cancer may direct to explaining significant advances in the etiology of cancer, potentially disclosing a novel paradigm of research for the management and prevention of cancer.",
author = "Marta Castiglia and Antonio Russo and Giuseppe Bronte and Francesco Passiglia and Ignacio Gil-Bazo and Marc Peeters and Marta Castiglia and Francesco Passiglia and Khan Shahanavaj and Carreca, {Anna P} and Christian Rolfo and {Del Pozo}, {Jos{\'e} Luis} and Rolfo, {Christian Diego}",
year = "2015",
language = "English",
volume = "15",
pages = "317--330",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",

}

TY - JOUR

T1 - Cancer and the microbiome: Potential applications as new tumor biomarker

AU - Castiglia, Marta

AU - Russo, Antonio

AU - Bronte, Giuseppe

AU - Passiglia, Francesco

AU - Gil-Bazo, Ignacio

AU - Peeters, Marc

AU - Castiglia, Marta

AU - Passiglia, Francesco

AU - Shahanavaj, Khan

AU - Carreca, Anna P

AU - Rolfo, Christian

AU - Del Pozo, José Luis

AU - Rolfo, Christian Diego

PY - 2015

Y1 - 2015

N2 - Microbial communities that colonize in humans are collectively described as microbiome. According to conservative estimates, about 15% of all types of neoplasms are related to different infective agents. However, current knowledge is not sufficient to explain how the microbiome contributes to the growth and development of cancers. Large and thorough studies involving colonized, diverse and complex microbiome entities are required to identify microbiome as a potential cancer marker and to understand how the immune system is involved in response to pathogens. This article reviews the existing evidence supporting the enigmatic association of transformed microbiome with the development of cancer through the immunological modification. Ascertaining the connection between microbiome and immunological responses with risk of cancer may direct to explaining significant advances in the etiology of cancer, potentially disclosing a novel paradigm of research for the management and prevention of cancer.

AB - Microbial communities that colonize in humans are collectively described as microbiome. According to conservative estimates, about 15% of all types of neoplasms are related to different infective agents. However, current knowledge is not sufficient to explain how the microbiome contributes to the growth and development of cancers. Large and thorough studies involving colonized, diverse and complex microbiome entities are required to identify microbiome as a potential cancer marker and to understand how the immune system is involved in response to pathogens. This article reviews the existing evidence supporting the enigmatic association of transformed microbiome with the development of cancer through the immunological modification. Ascertaining the connection between microbiome and immunological responses with risk of cancer may direct to explaining significant advances in the etiology of cancer, potentially disclosing a novel paradigm of research for the management and prevention of cancer.

UR - http://hdl.handle.net/10447/249741

UR - http://www.future-drugs.com/loi/era

M3 - Article

VL - 15

SP - 317

EP - 330

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

ER -